Mycoplasma gallisepticum: Current and developing means to control the avian pathogen

Journal of Applied Poultry Research

Volumn 14, Issue 4, 2005, Pages 757-763

  Evans, J D ^a   Leigh, S A ^a   Branton, S L ^a   Collier, S D ^a   Pharr, G T ^b   Bearson, S M D ^c  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Attenuated vaccine; Chronic respiratory disease; Mycoplasma gallisepticum; Mycoplasmosis; Poultry; Recombinant vaccine; Vaccine

Indexed keywords

AVES; BACTERIA (MICROORGANISMS); MYCOPLASMA GALLISEPTICUM; NEGIBACTERIA;

EID: 29744446436     PISSN: 10566171     EISSN: None     Source Type: Journal    
DOI: 10.1093/japr/14.4.757     Document Type: Review

References (73)

1. Kleven, S. H., H.-H. Fan, and K. S. Turner. 1998. Pen trial studies on the use of live vaccines to displace virulent Mycoplasma gallisepticum in chickens. Avian Dis. 42:300-306.
2. Stipkovits, L., and I. Kempf. 1996. Mycoplasmoses in poultry. Sci. Tech. Rev. Off. Int. Epizoot. 15:1495-1525.
3. Charleston, B. J., J. J. Gate, I. A. Aitken, and L. Reeve-Johnson. 1998. Assessment of the efficacy of tilmicosin as a treatment for Mycoplasma gallisepticum infections in chickens. Avian Pathol. 27:190-195.
4. Patterson, P. H. 1994. Coping with Mycoplasma gallisepticum. Internews 7:1-3.
5. Mohammed, H. O., T. E. Carpenter, and R. Yamamoto. 1987. Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. Avian Dis. 31:477-482.
6. Carpenter, T. E., E. T. Mallinson, K. F. Miller, R. F. Gentry, and L. D. Schwartz. 1981. Vaccination with F-strain Mycoplasma gallisepticum to reduce production losses in layer chickens. Avian Dis. 25:404-409.
7. Ley, D. H., and H. W. Yoder. 1997. Mycoplasma gallisepticum infection. Pages 194-207 in Diseases of Poultry. 10th ed. B.W. Calnek, ed. Iowa State Univ. Press, Ames, IA.
8. Thomas, C. B., and P. Sharp. 1990. Glycoconjugate heterogeneity among five strains of Mycoplasma gallisepticum. Avian Dis. 34:969-978.
9. Levisohn, S., and S. H. Kleven. 1981. Vaccination of chickens with nonpathogenic Mycoplasma gallisepticum as a means for displacement of pathogenic strains. Isr. J. Med. Sci. 17:669-673.
10. Vaillancourt, J.-P., and D. H. Ley. 2001. Mycoplasma gallisepticum outbreaks in NC. Poult. Dig. Online 3:1-2.
11. Rhorer, A. R. 2002. USDA, APHIS, National Poultry Improvement Plan, Conyers, GA. Personal communication.
12. Glisson, J. R., I. H. Cheng, J. Brown, and R. G. Stewart. 1989. The effect of oxytetracycline on the severity of airsacculitis in chickens infected with Mycoplasma gallisepticum. Avian Dis. 33:750-752.
13. Minion, F. C. 2002. Molecular pathogenesis of mycoplasma animal respiratory pathogens. Front. Biosci. 7:1410-1422.
14. Much, P., F. Winner, L. Stipkovits, R. Rosengarten, and C. Citti. 2002. Mycoplasma gallisepticum: influence of cell invasiveness on the outcome of experimental infection in chickens. FEMS Immunol. Med. Microbiol. 34:181-186.
15. Jan, G., M. LeHenaff, C. Fontenelle, and H. Wroblewski. 2001. Biochemical and antigenic characterisation of Mycoplasma gallisepticum membrane proteins P52 and P67 (pMGA). Arch. Microbiol. 177:81-90.
16. Goh, M. S., T. S. Gorton, M. H. Forsyth, K. E. Troy, and S. J. Geary. 1998. Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA). Microbiology 144:2971-2978.
17. Keeler, C. L., Jr., L. L. Hnatow, P. L. Whetzel, and J. E. Dohms. 1996. Cloning and characterization of a putative cytadhesin gene (mgc1) from Mycoplasma gallisepticum. Infect. Immun. 64:1541-1547.
18. Papazisi, L., K. E. Troy, T. S. Gorton, X. Liao, and S. J. Geary. 2000. Analysis of cytadherence-deficient, GapA-negative Mycoplasma gallisepticum strain R. Infect. Immun. 68:6643-6649.
19. Levisohn, S., and M. J. Dykstra. 1987. A quantitative study of single and mixed infection of the chicken trachea by Mycoplasma gallisepticum. Avian Dis. 31:1-12.
20. Boguslavsky, S., D. Menaker, I. Lysnyansky, T. Liu, S. Levisohn, R. Rosengarten, M. Garcia, and D. Yogev. 2000. Molecular characterization of the Mycoplasma gallisepticum pvpA gene which encodes a putative variable cytadhesin protein. Infect. Immun. 68:3956-3964.
21. Yogev, D., R. D. Menaker, K. Strutzberg, S. Levisohn, H. Hirchhoff, K. H. Hinz, and R. Rosengarten. 1994. A surface epitope undergoing high-frequency phase variation is shared by Mycoplasma gallisepticum and Mycoplasma bovis. Infect. Immun. 62:4962-4968.
22. low. Microbiology 149:2307-2316.
23. Berlic, T. M., D. Bencina, and P. Dovc. 2000. Sequence polymorphisms within the pMGA genes and pMGA antigenic variants in Mycoplasma gallisepticum. FEMS Microbiol. Lett. 184:133-139.
24. Markham, P. F., M. D. Glew, K. G. Whithear, and I. D. Walker. 1993. Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of Mycoplasma gallisepticum. Infect. Immun. 61:903-909.
25. Bencina, D. 2002. Haemagglutinins of pathogenic avian mycoplasmas. Avian Pathol. 31:535-547.
26. Winner, F., R. Rosengarten, and C. Citti. 2000. In vitro cell invasion of Mycoplasma gallisepticum. Infect. Immun. 68:4238-4244.
27. Liu, T., M. Garcia, S. Levisohn, D. Yogev, and S. H. Kleven. 2001. Molecular variability of the adhesin-eneoding gene pvpA among Mycoplasma gallisepticum strains and its application in diagnosis. J. Clin. Microbiol. 39:1882-1888.
28. Rhorer, A. R. 2004. USDA, APHIS, National Poultry Improvement Plan, Conyers, GA. Personal communication.
29. Whithear, K.G. Control of avian mycoplasmosis by vaccination. 1996. Sci. Tech. Rev. Off. Int. Epizoot. 15:1527-1553.
30. Branton, S. L., S. M. D. Bearson, B. L. Bearson, B. D. Lott, W. R. Maslin, S. D. Collier, G. T. Pharr, and D. L. Boykin. 2002. The effects of 6/85 live Mycoplasma gallisepticum vaccine in commercial layer hens over a 43-week laying cycle on egg production, selected egg quality parameters, and egg size distribution when challenged before beginning of lay. Avian Dis. 46:423-428.
31. Evans, R. D., and Y. S. Hafez. 1992. Evaluation of a Mycoplasma gallisepticum strain exhibiting reduced virulence for prevention and control of poultry mycoplasmosis. Avian Dis. 36:197-201.
32. Whithear, K. G., K. E. Soeripto, K. E. Harringan, and E. Ghiocas. 1990. Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine. Aust. Vet. J. 67:159-165.
33. Whithear, K. G., K. E. Soeripto, K. E. Harrigan, and E. Ghiocas. 1990. Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine. Austr. Vet. J. 67:168-174.
34. Gingerich, E. 2002. Vaccine and vaccination for Mycoplasma gallisepticum (MG). Proc. Cornell Poult. Conf., Ithaca, NY.
35. Yoshida, S., A. Fujisawa, Y. Tsuzaki, and S. Saitoh. 2000. Identification and expression of a Mycoplasma gallisepticum surface antigen recognized by a monoclonal antibody capable of inhibiting both growth and metabolism. Infect. Immun. 68:3186-3192.
36. Self, J. 2003. Cal-Maine Foods, Inc., Jackson, MS. Personal communication.
37. Branton, S. L., and J. W. Deaton. 1985. Egg production, egg weight, eggshell strength, and mortality in three strains of commercial layers vaccinated with F strain Mycoplasma gallisepticum. Avian Dis. 29:832-837.
38. Luginbuhl, R. E., M. E. Toutellotte, and M. N. Frazier. 1967. Mycoplasma gallisepticum: Control by immunization. Ann. NY Acad. Sci. 143:234-238.
39. Lin, M. Y., and S. H. Kleven. 1982. Egg transmission of two strains of Mycoplasma gallisepticum in chickens. Avian Dis. 26:487-495.
40. US Animal Health Association. 2002. Report of the committee on transmissable diseases of poultry and other avian species. USAHA, Richmond, VA.
41. Abd-El-Motelib, T. Y., and S. H. Kleven. 1993. A comparative study of Mycoplasma gallisepticum vaccines in young chickens. Avian Dis. 37:981-987.
42. Turner, K. S., and S. H. Kleven. 1998. Eradication of live F strain Mycoplasma gallisepticum vaccine using live ts-11 on a multiage commercial layer farm. Avian Dis. 42:404-407.
43. Ley, D. H. 2003. Mycoplasma gallisepticum infection. Pages 722-744 in Diseases of Poultry. 11th ed. Y. M. Saif, H. J. Barnes, J. R. Glisson, A. M. Fadly, L. R. McDougald and D. E. Swayne, ed. Iowa State Univ. Press, Ames, IA.
44. Ferguson, N. M., D. Hermes, V. A. Leiting, and S. H. Kleven. 2003. Characterization of a naturally occurring infection of a Mycoplasma gallisepticum house finch-like strain in turkey breeders. Avian Dis. 47:523-530.
45. Ferguson, N. M., V. A. Leiting, and S. H. Kleven. 2004. Safety and efficacy of the avirulent Mycoplasma gallisepticum strain K5054 as a live vaccine in poultry. Avian Dis. 48:91-99.
46. Liljeqvist, S., and S. Stahl. 1999. Review article: Production of recombinant subunit vaccines: Protein immunogens, live delivery systems and nucleic acid vaccines. J. Biotechnol. 73:1-33.
47. McGhee, J. R., J. Mestiecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 10:75-88.
48. Voelker, L. L., and K. Dybvig. 1996. Gene transfer in Mycoplasma arthritidis: transformation, conjugal transfer of Tn916, and evidence for a restriction system recognizing AGCT. J. Bacteriol. 178:6078-6081.
49. Mudahi-Orenstein, S., S. Levisohn, S. J. Geary, and D. Yogev. 2003. Cytadherence-deficient mutants of Mycoplasma gallisepticum generated by transposon mutagenesis. Infect. Immun. 71:3812-3820.
50. Pour-El, I., C. Adams, and F. C. Minion. 2002. Construction of mini-Tn4001tet and its use in Mycoplasma gallisepticum. Plasmid 47:129-137.
51. Liu, L., K. Dybvig, V. S. Panangala, V. L. Van Santen, and C. T. French. 2000. GAA trinucleotide repeat region regulates M9/pMGA gene expression in Mycoplasma gallisepticum. Infect. Immun. 68:871-876.
52. Whetzel, P. L., L. L. Hnatow, C. L. Keeler, and J. E. Dohms. 2003. Transposon mutagenesis of Mycoplasma gallisepticum. Plasmid 49:34-43.
53. Cao, J., P. A. Kapke, and F. C. Minion. 1994. Transformation of Mycoplasma gallisepticum with Tn916, Tn4001, and integrative plasmid vectors. J. Bacteriol. 176:4459-4462.
54. Ruffin, D. C., V. L. Van Santen, Y. Zhang, L. L. Voelker, V. S. Panangala, and K. Dybvig. 2000. Transposon mutagenesis of Mycoplasma gallisepticum by conjugation with Enterococcus faecalis and determination of insertion site by direct genomic sequencing. Plasmid 44:191-195.
55. Dybvig, K., C. T. French, and L. L. Voelker. 2000. Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis. J. Bacteriol. 182:4343-4347.
56. Knudtson, K. L., and F. C. Minion. 1993. Construction of Tn4001lac derivatives to be used as promoter probe vectors in mycoplasmas. Gene 137:217-222.
57. Liu, L., V. S. Panangala, and K. Dybvig. 2002. Trinucleotide GAA repeats dictate pMG A gene expression in Mycoplasma gallisepticum by affecting spacing between flanking regions. J. Bacteriol. 184:1335-1339.
58. Hnatow, L. L., C. L. Keeler, Jr., L. L. Tessmer, K. Czymmek, and J. E. Dohms. 1998. Characterization of MGC2, a Mycoplasma gallisepticum cytadhesin with homology to the Mycoplasma pneumoniae 30-kilodalton protein P30 and Mycoplasma genitalium P32. Infect. Immun. 66:3436-3442.
59. Pharr, G. T., S. L. Branton, L. A. Hanson, F. C. Minion, M. B. Hughlett, and X. Wan. 2002. Characterization of pMGA genes from the F-strain (vaccine strain) of Mycoplasma gallisepticum. Int. J. Poult. Sci. 1:66-73.
60. Glew, M. D., N. Baseggio, P. F. Markham, G. F. Browning, and I. D. Walker. 1998. Expression of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA trinucleotide repeat lengths within the 5′ noncoding regions. Infect. Immun. 66:5833-5841.
61. Markham, P. F., M. D. Glew, M. R. Brandon, I. D. Walker, and K. G. Whithear. 1992. Characterization of a major hemagglutinin protein from Mycoplasma gallisepticum. Infect. Immun. 60:3885-3891.
62. Papazisi, L., S. Frasca, Jr., M. Gladd, X. Liao, D. Yogev, and S. J. Geary. 2002. GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence. Infect. Immun. 70:6839-6845.
63. Papazisi, L., L. K. Silbart, S. Frasca, D. Rood, X. Liao, M. Gladd, M. A. Javed, and S. J. Geary. 2002. A modified live Mycoplasma gallisepticum vaccine to protect chickens from respiratory disease. Vaccine 20:3709-3719.
64. Hopkins, B. 2005. Biomune Vaccines. Personal communication.
65. Jordan, F. T., and M. M. Amin. 1980. A survey of Mycoplasma infections in domestic poultry. Res. Vet. Sci. 28:96-100.
66. Wang, Y., K. G. Whithear, and E. Ghiocas. 1990. Isolation of Mycoplasma gallinarum and M. gallinaceum from the reproductive tract of hens. Austr. Vet. J. 67:31-32.
67. Dierks, R. E., J. A. Newman, and B. S. Pomeroy. 1967. Characterization of avian mycoplasma. Ann. NY Acad. Sci. 143:170-189.
68. Taylor-Robinson, D., and J. D. Cherry. 1972. A non-pathogenic mycoplasma inhibiting the effect of a pathogenic mycoplasma in organ culture. J. Med. Microbiol. 5:291-298.
69. Branton, S. L., S. M. D. Bearson, B. L. Bearson, W. R. Maslin, S. D. Collier, J. D. Evans, D. M. Miles, and G. T. Pharr. 2003. Mycoplasma gallinarum infection in commercial layers and onset of fatty liver hemorrhagic syndrome. Avian Dis. 47:458-462.
70. Bencina, D., A. Svetlin, D. Dorrer, and T. Tadina-Jaksic. 1991. Humoral and local antibodies in chickens with mixed infection with three Mycoplasma species. Avian Pathol. 20:325-334.
71. Ben Abdelmoumen, B., and R. S. Roy. 1995. Antigenic relatedness between seven avian mycoplasma species as revealed by Western blot analysis. Avian Dis. 39:250-262.
72. Ahuja, K. L., and N. K. Chandiramani. 1976. Studies on the antigenic relationship between Mycoplasma gallisepticum and Mycoplasma gallinarum. Indian J. Anim. Sci. 46:146-151.
73. Wan, X., S. L. Branton, L. A. Hanson, and G. T. Pharr. 2004. Identification and initial characterization of a putative Mycoplasma gallinarum leucine aminopeptidase gene. Curr. Microbiol. 48:32-38.